A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

His current research aims to understand the post-transcriptional and epigenetic mechanisms that govern stem cell potency and cell fate decisions. The ultimate goal is to utilize these mechanistic ...

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael E Carazo Salas ...

Bluebird Bio and Xcellbio have entered into an agreement to support the commercialization of sickle cell gene therapy ...

The US Food and Drug Administration (FDA) has issued a draft guidance for testing the potency of cellular and gene therapy (CGT) products. The guidance clarifies the potency information needed to ...

Our research is focused on developing the basic biology and technology that will underpin the use of human Pluripotent Stem Cells for applications in medicine, whether for a direct use in regenerative ...